In the opaque, frustrating world of healthcare billing, a denied claim is more than a line item. It is a delay in care, a drain on administrative staff, and a direct hit to a clinic’s financial health. Orchid Healthcare Technologies is building a tool to catch those errors before they leave the building, focusing first on a single, specific type of claim: those submitted by podiatrists in Florida under Original Medicare. It is a narrow wedge, but one its founder believes is the right place to start proving that artificial intelligence can bring clarity and defensibility to a process mired in complexity.
A Wedge of Podiatry in Florida
Orchid’s initial market is deliberately precise. The company is targeting Florida Original Medicare podiatry, a niche defined by a specific geography, a specific payer, and a specific medical specialty. This focus allows the startup to deeply encode the reimbursement rules, local coverage determinations, and documentation requirements for a finite set of procedures. The product, called Orchid CodeGuard, is a software-as-a-service platform designed to be used by revenue cycle management (RCM) teams and professional specialty/outpatient providers before a claim is submitted [orchidhealthtech.com/for-rcm-teams, Author note, Sep 2026]. It promises to evaluate the claim, medical record, applicable reimbursement requirements, supporting/conflicting evidence, and uncertainty, then present a reviewable finding, keeping the underlying evidence and governing rules visible to the human reviewer [orchidhealthtech.com/how-it-works, Author note, Sep 2026].
From Payer Experience to Founder-Led Build
The company is the solo venture of Andrew Shirer, a healthcare operations and consulting leader with over 15 years of experience on the payer side of the industry [LinkedIn, retrieved 2026]. His career spans operational leadership inside health plans and consulting work across more than 20 payer organizations, giving him a ground-level view of the adjudication process that ultimately determines whether a claim is paid [LinkedIn, retrieved 2026]. Orchid describes itself as founder-led and, so far, founder-built, suggesting a very lean early-stage operation focused on product development [orchidhealthtech.com/about, retrieved 2026]. Shirer has participated in industry discussions, including the #BeckersHealthcare Podcast, to talk about innovation in the space [LinkedIn, retrieved 2026].
The Path to Product Validation
Publicly, Orchid’s development appears to be in a controlled product validation phase, a common and necessary stage for healthtech tools that will eventually handle real claims data. The company has stated it is working with synthetic claims, with the next step being controlled product validation using authorized historical claims and supporting records in partnership with RCM teams [LinkedIn, retrieved 2026]. This methodical approach is prudent from a regulatory and technical standpoint, and it underscores the distance between concept and commercial deployment. The company’s mission,to return owed revenue to providers so clinicians can focus on patients,remains a future goal awaiting this validation [orchidhealthtech.com/about, retrieved 2026].
| Aspect | Orchid Healthcare Technologies' Status |
|---|---|
| Product Stage | Development with synthetic claims; controlled validation planned [LinkedIn, retrieved 2026] |
| Initial Market | Florida Original Medicare podiatry [LinkedIn, retrieved 2026] |
| Founding Team | Solo founder Andrew Shirer, with payer-side operations background [LinkedIn, retrieved 2026] |
| Public Traction | No named customers or commercial partnerships yet verified |
| Funding | No verifiable public funding announcements |
The Risks of a Narrow Lane
Orchid’s focused strategy carries inherent trade-offs. Starting with such a specific wedge reduces initial market size and may slow top-line growth, a potential concern for future investors. The company also enters a field crowded with established revenue cycle management software giants and a growing number of AI-powered coding and billing assistants. Without disclosed funding or named pilot customers, it operates without the external validation that often de-risks early-stage healthtech bets. The company’s success will hinge on executing its validation plan and demonstrating that its AI can achieve a materially higher accuracy or efficiency rate than existing rules-based systems or human reviewers to justify a switch.
- Market Concentration Risk. The deep focus on Florida podiatry is a double-edged sword. It allows for precision but creates a ceiling; expansion into other specialties or states will require rebuilding and validating new rule sets.
- The Validation Hurdle. Moving from synthetic data to real historical claims is a critical technical and commercial leap. The results of this controlled product validation will be the first true test of the platform’s utility.
- Founder Dependency. As a solo, founder-built operation, the company’s pace and technical depth are currently tied to one individual. Scaling will require attracting both technical talent and commercial leadership.
For podiatrists treating Medicare patients in Florida today, the standard of care for claim submission is a manual, often stressful process. It relies on the coder’s knowledge of constantly evolving Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs), cross-referenced with pages of clinical notes. Mistakes lead to lengthy denial letters, appeals, and ultimately, unpaid work. Orchid’s bet is that by automating this review with an AI that understands the rules and the records, it can turn a loss-prone administrative burden into a predictable, defensible financial step. The patient population,older adults with foot and ankle conditions,stands to benefit indirectly from clinics that are financially healthier and staff who are less burdened by bureaucratic friction. The next twelve months, focused on that controlled validation, will determine if the technology is ready for that responsibility.
Sources
- [orchidhealthtech.com, retrieved 2026] About Orchid Healthcare Technologies | https://orchidhealthtech.com/about
- [orchidhealthtech.com, retrieved 2026] Orchid Healthcare Technologies | Claim Intelligence for Specialty Practices | https://orchidhealthtech.com/
- [LinkedIn, retrieved 2026] Orchid Healthcare Technologies Company Page | https://www.linkedin.com/company/orchidhealthtech
- [LinkedIn, retrieved 2026] Andrew Shirer Profile | https://www.linkedin.com/in/andrewshirer/
- [orchidhealthtech.com/for-rcm-teams, Author note, Sep 2026] For RCM Teams | Orchid Healthcare Technologies | https://orchidhealthtech.com/for-rcm-teams
- [orchidhealthtech.com/how-it-works, Author note, Sep 2026] How It Works | Orchid Healthcare Technologies | https://orchidhealthtech.com/how-it-works